CLINIQUE ACNE SOLUTIONS CLEANSING FOAM- salicylic acid liquid 
CLINIQUE LABORATORIES LLC

----------

CLINIQUE ACNE SOLUTIONS CLEANSING FOAM

Drug Facts

Active ingredient

Salicylic acid 2%

Purpose

Acne treatment

Uses

Warnings

For external use only

When using this product using other topical acne drugs at the same time or right after use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive ingredients

water\aqua\eau • glycerin • butylene glycol • sodium methyl cocoyl taurate • sucrose • disodium phosphate • arginine cocoate • laminaria saccharina extract • caffeine • algae extract • cola acuminata (kola) seed extract • sea whip extract • peg/ppg-18/18 dimethicone • sodium hyaluronate • ppg-6-decyltetradeceth-30 • lactobacillus ferment • stearamidopropyl dimethylamine • acetyl glucosamine • capryloyl glycine • 10-hydroxydecanoic acid • polyquaternium-7 • phospholipids • stearic acid • sodium hydroxide • disodium edta • phenoxyethanol • chloroxylenol [iln41840]

PRINCIPAL DISPLAY PANEL - 125 ml Bottle Label

CLINIQUE

acne solutions

cleansing

foam

STEP 1

SALICYLIC ACID ACNE MEDICATION

4.2 FL.OZ.LIQ./125 ml e

Principal Display Panel

CLINIQUE ACNE SOLUTIONS CLEANSING FOAM 
salicylic acid liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49527-079
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
SODIUM METHYL COCOYL TAURATE (UNII: JVL98CG53G)  
SUCROSE (UNII: C151H8M554)  
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F)  
ARGININE COCOATE (UNII: 951Q8XZ62H)  
SACCHARINA LATISSIMA (UNII: 68CMP2MB55)  
CAFFEINE (UNII: 3G6A5W338E)  
CARRAGEENAN (UNII: 5C69YCD2YJ)  
COLA ACUMINATA SEED (UNII: 1F8VIW1479)  
PSEUDOPTEROGORGIA ELISABETHAE (UNII: UDY3H1OUX5)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
DECYLTETRADECETH-30 (UNII: 6FLU72F7LG)  
LIMOSILACTOBACILLUS REUTERI (UNII: 9913I24QEE)  
STEARAMIDOPROPYL DIMETHYLAMINE (UNII: K7VEI00UFR)  
N-ACETYLGLUCOSAMINE (UNII: V956696549)  
CAPRYLOYL GLYCINE (UNII: 8TY5YO42NJ)  
10-HYDROXYDECANOIC ACID (UNII: NP03XO416B)  
POLYQUATERNIUM-7 (70/30 ACRYLAMIDE/DADMAC; 1600000 MW) (UNII: 0L414VCS5Y)  
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
CHLOROXYLENOL (UNII: 0F32U78V2Q)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49527-079-01125 mL in 1 BOTTLE; Type 0: Not a Combination Product07/21/202011/23/2025
2NDC:49527-079-0250 mL in 1 BOTTLE; Type 0: Not a Combination Product03/02/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00607/21/202011/23/2025
Labeler - CLINIQUE LABORATORIES LLC (044475127)
Registrant - Estee Lauder Companies Inc. (790802086)
Establishment
NameAddressID/FEIBusiness Operations
PALC078364654label(49527-079) , pack(49527-079)
Establishment
NameAddressID/FEIBusiness Operations
The Estee Lauder Inc802599436manufacture(49527-079) , pack(49527-079) , label(49527-079)
Establishment
NameAddressID/FEIBusiness Operations
NORTHTEC LLC943871157label(49527-079) , pack(49527-079)
Establishment
NameAddressID/FEIBusiness Operations
NORTHTEC KEYSTONE949264774label(49527-079) , pack(49527-079)

Revised: 4/2024
Document Id: 16c90e4a-6933-b0e4-e063-6394a90a6b92
Set id: 261223c6-6d2d-4c9d-90c9-a2ac3d3da07e
Version: 15
Effective Time: 20240423
 
CLINIQUE LABORATORIES LLC